DsRNA and the innate antiviral immune response

Future Virology

Volumn 5, Issue 3, 2010, Pages 325-341

  Dewitte Orr, Stephanie J ^a   Mossman, Karen L ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

DsRNA; Interferon; RIG I; Scavenger receptor sensor; Therapeutic virus; Toll like receptor 3

Indexed keywords

CRYOPYRIN; DOUBLE STRANDED RNA; INTERFERON; MONOCLONAL ANTIBODY; PATTERN RECOGNITION RECEPTOR; POLYCLONAL ANTIBODY; PROTEIN KINASE R; RETINOIC ACID INDUCIBLE PROTEIN I; RIBONUCLEASE; RINTATOLIMOD; TOLL LIKE RECEPTOR 3;

ADENOVIRUS; ANTIVIRAL ACTIVITY; ENCEPHALOMYOCARDITIS VIRUS; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; IMMUNOMODULATION; INFLUENZA VIRUS A; INNATE IMMUNITY; MOLECULAR INTERACTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN SECONDARY STRUCTURE; RECEPTOR BINDING; REOVIRUS; REVIEW; RNA STRUCTURE; RNA SYNTHESIS; RUBELLA VIRUS; SARS CORONAVIRUS; SEMLIKI FOREST ALPHAVIRUS; SIMIAN VIRUS 40; SINDBIS VIRUS; VACCINIA VIRUS; VESICULAR STOMATITIS VIRUS; VIRUS IMMUNITY; VIRUS INFECTION; VIRUS REPLICATION; WEST NILE FLAVIVIRUS; X RAY DIFFRACTION;

EID: 77952258317     PISSN: 17460794     EISSN: None     Source Type: Journal    
DOI: 10.2217/fvl.10.18     Document Type: Review

References (159)

1. Janeway CA, Medzhitov R: Innate immune recognition. Ann. Rev. Immunol. 20, 197-216 (2002).
2. Randall R, Goodbourn S: Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J. Gen. Virol. 89(1), 1-47 (2008).
3. Owen D, Gale M: Fighting the flu with inflammasome signaling. Immunity 30, 476-478 (2009).
4. Sheppard P, Kindsvogel W, Xu W et al.: IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat. Immunol. 4(1), 63-68 (2003).
5. Nicholson AW: Structure, reactivity, and biology of double-stranded RNA. Prog. Nucleic Acid Res. Mol. Biol. 52, 1-65 (2006).
6. Tang RS, Draper DE: On the use of phasing experiments to measure helical repeat and bulge loop-associated twist in RNA. Nucleic Acids Res. 22(5), 835-841 (1994).
7. Gast FU, Sanger HL: Gel dependence of electrophoretic mobilities of double-stranded and viroid RNA and estimation of the contour length of a viroid by gel electrophoresis Electrophoresis 15(12), 1493-1498 (1994).
8. Van Den Hout M, Vilfan ID, Hage S, Dekker NH: Direct force measurements on double-stranded RNA in solid-state nanopores. Nano Lett. 10(2), 701-707 (2010).
9. Libonati M, Carsana A, Furia A: Double-stranded RNA. Mol. Cell. Biochem. 31(3), 147-164 (1980).
10. Schonborn J, Oberstrass J, Breyel E, Tittgen J, Schumacher J, Lukacs N: Monoclonal antibodies to double-stranded RNA as probes of RNA structure in crude nucleic acid extracts. Nucleic Acids Res. 19(11), 2993-3000 (1991).
11. DeWitte-Orr SJ, Mehta DR, Collins SE, Suthar MS, Gale M, Mossman KL: Long double-stranded RNA induces an antiviral response independent of IFN regulatory factor 3, IFN-b promoter stimulator 1, and IFN. J. Immunol. 183(10), 6545-6553 (2009).
12. Kato H, Takeuchi O, Mikamo-Satoh E et al.: Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J. Exp. Med. 205(7), 1601-1610 (2008).
13. Weber F, Wagner V, Rasmussen S, Hartmann R, Paludan S: Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses. J. Virol. 80(10), 5059-5064 (2006).
14. Borst P, Weissmann C: Replication of viral RNA, 8. Studies on the enzymatic mechanism of replication of ms2 RNA. Proc. Natl Acad. Sci. USA 54(3), 982-987 (1965).
15. Jelinek W, Darnell JE: Double-stranded regions in heterogeneous nuclear RNA from Hela cells. Proc. Natl Acad. Sci. USA 69(9), 2537-2541 (1972).
16. Calvet JP, Pederson T: Secondary structure of heterogeneous nuclear RNA: two classes of double-stranded RNA in native ribonucleoprotein. Proc. Natl Acad. Sci. USA 74(9), 3705-3709 (1977).
17. Lehner B, Williams G, Campbell RD, Sanderson CM: Antisense transcripts in the human genome. Trends Genet. 18(2), 63-65 (2002).
18. Werner A: Natural antisense transcripts. RNA Biol. 2(2), 53-62 (2005).
19. Matranga C, Zamore PD: Small silencing RNAs. Curr. Biol. 17(18), R789-R793 (2007).
20. Werner A, Carlile M, Swan D: What do natural antisense transcripts regulate? RNA Biol. 6(1), 43-48 (2009).
21. Umbach JL, Cullen BR: The role of RNAi and microRNAs in animal virus replication and antiviral immunity. Genes Dev. 23(10), 1151-1164 (2009).
22. Wang Q, Carmichael G: Effects of length and location on the cellular response to double-stranded RNA. Microbiol. Mol. Biol. Rev. 68(3), 432-452 (2004).
23. Marques JT, Devosse T, Wang D et al.: A structural basis for discriminating between self and nonself double-stranded RNAs in mammalian cells. Nat. Biotechnol. 24(5), 559-565 (2006).
24. Nallagatla SR, Toroney R, Bevilacqua PC: A brilliant disguise for self RNA: 5́-end and internal modifications of primary transcripts suppress elements of innate immunity. RNA Biol. 5(3), 140-144 (2008).
25. de Bouteiller O, Merck E, Hasan U et al.: Recognition of double-stranded RNA by human Toll-like receptor 3 and downstream receptor signaling requires multimerization and an acidic pH. J. Biol. Chem. 280(46), 38133-38145 (2005).
26. Lemaire PA, Anderson E, Lary J, Cole JL: Mechanism of PKR activation by dsRNA. J. Mol. Biol. 381(1), 351-360 (2008).
27. Jacobs B, Langland J: When two strands are better than one: the mediators and modulators of the cellular responses to double-stranded RNA. Virology 219(2), 339-349 (1996). (Pubitemid 126407667)
28. Kumar M, Carmichael GG: Antisense RNA: function and fate of duplex RNA in cells of higher eukaryotes. Microbiol. Mol. Biol. Rev. 62(4), 1415-1434 (1998).
29. Urbano P, Urbano FG: The reoviridae family. Comp. Immunol. Microbiol. Infect. Dis. 17(3-4), 151-161 (1994).
30. Majde J, Brown R, Jones M et al.: Detection of toxic viral-associated double-stranded RNA (dsRNA) in influenza-infected lung. Micro. Pathog. 10(2), 105-115 (1991).
31. Aliyari R, Ding S-W: RNA-based viral immunity initiated by the Dicer family of host immune receptors. Immunol. Rev. 227(1), 176-188 (2009).
32. Deddouche S, Matt N, Budd A et al.: The DExD/H-box helicase Dicer-2 mediates the induction of antiviral activity in drosophila. Nat. Immunol. 9(12), 1425-1432 (2008).
33. Matskevich AA, Moelling K: Dicer is involved in protection against influenza A virus infection. J. Gen. Virol. 88(Pt 10), 2627-2635 (2007).
34. Cox H: Viral and rickettsial toxins. Annu. Rev. Microbiol. 7, 197-218 (1953).
35. Isaacs A, Lindemann J: Virus interference. I. The interferon. Proc. Roy. Soc. B 147, 258-267 (1957).
36. Montagnier L, Sanders FK: Replicative form of encephalomyocarditis virus ribonucleic acid. Nature 199, 664-667 (1963).
37. Lampson GP, Tytell AA, Field AK, Nemes MM, Hilleman MR: Inducers of interferon and host resistance. I. Double-stranded RNA from extracts of penicillium funiculosum. Proc. Natl Acad. Sci. USA 58(2), 782-789 (1967).
38. No authors listed. Hope to end virus disease. Sci. News 92, 173-174 (1967).
39. Carter W, De Clercq E: Viral infection and host defense. Science 186(4170), 1172-1178 (1974).
40. Majde J: Viral double-stranded RNA, cytokines and the flu. J. Interferon Cytokine Res. 20, 259-272 (2000).
41. Dinger M, Mercer T, Mattick J: RNAs as extracellular signaling molecules. J. Mol. Endocrin. 40, 151-159 (2008).
42. Marcus PI, Sekellick MJ: Defective interfering particles with covalently linked +/-RNA induce interferon. Nature 266(5605), 815-819 (1977).
43. DeWitte-Orr SJ, Collins SE, Bauer CMT, Bowdish DM, Mossman KL: An accessory to the 'trinity': SR-As are essential pathogen sensors of extracellular dsRNA, mediating entry and leading to subsequent type I IFN responses. PLoS Pathog. 6(3), e1000829 (2010).
44. Fang J, Bredow S, Taishi P, Majde J, Krueger J: Synthetic influenza viral double-stranded RNA induces an acute-phase response in rabbits. J. Med. Virol. 57(2), 198-203 (1999).
45. Majde J, Guha-Thakurta N, Chen Z, Bredow S, Krueger J: Spontaneous release of stable viral double-stranded RNA into the extracellular medium by influenza virus-infected MDCK epithelial cells: implications for the viral acute phase response. Arch. Virol. 143(12), 2371-2380 (1998).
46. von Herrath M, Bot A: Immune responsiveness, tolerance and dsRNA: implications for traditional paradigms. Trends Immunol. 24(6), 289-292 (2003).
47. Saleh MC, Tassetto M, van Rij RP et al: Antiviral immunity in Drosophila requires systemic RNA interference spread. Nature 458(7236), 346-350 (2009).
48. Bobst A, Torrence P, Kouidou S, Witkop B: Dependence of interferon induction on nucleic acid conformation. Proc. Natl Acad. Sci. USA 73(11), 3788-3792 (1976).
49. Saunders LR, Barber GN: The dsRNA binding protein family: critical roles, diverse cellular functions. FASEB J. 17(9), 961-983 (2003).
50. Pirher N, Ivicak K, Pohar J, Bencina M, Jerala R: A second binding site for double-stranded RNA in TLR3 and consequences for interferon activation. Nat. Struct. Mol. Biol. 15(7), 761-763 (2008).
51. Liu L, Botos I, Wang Y et al.: Structural basis of Toll-like receptor 3 signaling with double-stranded RNA. Science 320(5874), 379-381 (2008).
52. Takahasi K, Kumeta H, Tsuduki N et al.: Solution structures of cytosolic RNA sensor MDA5 and LGP2 C-terminal domains: identification of the RNA recognition loop in RIG-I-like receptors. J. Biol. Chem. 284(26), 17465-17474 (2009).
53. Takahasi K, Yoneyama M, Nishihori T et al.: Nonself RNA-sensing mechanism of RIG-I helicase and activation of antiviral immune responses. Mol. Cell 29(4), 428-440 (2008).
54. Hampton R, Golenbock D, Penman M, Krieger M, Christian R: Recognition and plasma clearance of endotoxin by scavenger receptors Nature 352(6333), 342-344 (1991).
55. Limmon G, Arredouani M, McCann K, Minor R, Kobzik L, Imani F: Scavenger receptor class-A is a novel cell surface receptor for double-stranded RNA. FASEB J. 22(1), 159-167 (2008).
56. Murphy J, Tedbury P, Homer-Vanniasinkam S, Walker J, Ponnambalam S: Biochemistry and cell biology of mammalian scavenger receptors Atherosclerosis 182(1), 1-15 (2005).
57. Brown MS, Goldstein JL: Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Ann. Rev. Biochem. 52(1), 223-261 (1983).
58. Suzuki H, Kurihara Y, Takeya M et al.: A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature 386(6622), 292-296 (1997).
59. Cavassani K, Ishii M, Wen H et al.: TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events. J. Exp. Med. 381(2), 351-360 (2008).
60. Creagh E, O'Neill L: TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity. Trends Immunol. 27(8), 352-357 (2006).
61. Meylan E, Tschopp J, Karin M: Intracellular pattern recognition receptors in the host response. Nature 442(7098), 39-44 (2006).
62. Takeuchi O, Akira S: Innate immunity to virus infection. Immunol. Rev. 227(1), 75-86 (2009).
63. Yanai H, Ban T, Wang Z et al.: HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses. Nature 462(7269), 99-103 (2009).
64. Sen GC, Sarkar SN: Transcriptional signaling by double-stranded RNA: role of TLR3. Cytokine Growth Factor Rev. 16(1), 1-14 (2005).
65. Matsumoto M, Seya T: TLR3: Interferon induction by double-stranded RNA including poly(I:C). Adv. Drug Del. Rev. 60(7), 805-812 (2008).
66. Kawai T, Akira S: The roles of TLRs, RLRs and NLRs in pathogen recognition. Int. Immunol. 21(4), 317-337 (2009).
67. Bell JK, Mullen GED, Leifer CA, Mazzoni A, Davies DR, Segal DM: Leucine-rich repeats and pathogen recognition in Toll-like receptors. Trends Immunol. 24(10), 528-533 (2003).
68. Kim Y, Brinkmann M, Paquet M, Ploegh H: UNC93B1 delivers nucleotide-sensing Toll-like receptors to endolysosomes. Nature 452(7184), 234-238 (2008).
69. Matsumoto M, Kikkawa S, Kohase M, Miyake K, Seya T: Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling. Biochem. Biophys. Res. Commun. 293(5), 1364-1369 (2002).
70. Leonard J, Ghirlando R, Askins J et al.: The TLR3 signaling complex forms by cooperative receptor dimerization. Proc. Natl Acad. Sci. USA 105(1), 258-263 (2008).
71. Fukuda K, Watanabe T, Tokisue T et al.: Modulation of double-stranded RNA recognition by the N-terminal histidine-rich region of the human Toll-like receptor 3. J. Biol. Chem. 283(33), 22787-22794 (2008).
72. Saito T, Gale M Jr: Differential recognition of double-stranded RNA by RIG-I-like receptors in antiviral immunity. J. Exp. Med. 205(7), 1523-1527 (2008).
73. Venkataraman T, Valdes M, Elsby R et al.: Loss of DExD/H box RNA helicase LGP2 manifests disparate antiviral responses. J. Immunol. 178(10), 6444-6455 (2007).
74. Schlee M, Hartmann E, Coch C et al.: Approaching the RNA ligand for RIG-I? Immunol. Rev. 227(1), 66-74 (2009).
75. Schmidt A, Schwerd T, Hamm W et al.: 5́-triphosphate RNA requires base-paired structures to activate antiviral signaling via RIG-I. Proc. Natl Acad. Sci. USA 106(29), 12067-12072 (2009).
76. Schlee M, Roth A, Hornung V et al.: Recognition of 5́ triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus. Immunity 31(1), 25-34 (2009).
77. Gitlin L, Barchet W, Gilfillan S et al.: Essential role of MDA-5 in type I IFN responses to polyriboinosinic:polyribocytidyl ic acid and encephalomyocarditis picornavirus. Proc. Natl Acad. Sci. USA 103(2), 8459-8464 (2006).
78. Hornung V, Ellegast J, Kim S et al.: 5́-triphosphate RNA is the ligand for RIG-I. Science 314(5801), 994-997 (2006).
79. Pichlmair A, Schulz O, Tan CP et al: RIG-I-mediated antiviral responses to single-stranded RNA bearing 5́-phosphates. Science 314(5801), 997-1001 (2006).
80. Kumar H, Kawai T, Kato H et al.: Essential role of IPS-1 in innate immune responses against RNA viruses. J. Exp. Med. 203(7), 1795-1803 (2006).
81. Kawai T, Takahashi K, Sato S et al.: IPS-1, an adaptor triggering RIG-I-and MDA5-mediated type I interferon induction. Nat. Immunol. 6(10), 981-988 (2005).
82. Xu L, Wang Y, Han K, Li L, Zhai Z, Shu H: VISA is an adapter protein required for virus-triggered IFN-b signaling. Mol. Cell 19(6), 727-740 (2005).
83. Chiu Y-H, Macmillan JB, Chen ZJ: RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway Cell 138(3), 576-591 (2009).
84. Ablasser A, Bauernfeind F, Hartmann G, Latz E, Fitzgerald KA, Hornung V: RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate. Nat. Immunol. 10(10), 1065-1072 (2009).
85. Franchi L, Eigenbrod T, Muñoz-Planillo R, Nuñez G: The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat. Immunol. 10(3), 241-247 (2009).
86. Kanneganti T, Ozoren N, Body-Malapel M et al.: Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3. Nature 440(9), 233-236 (2006).
87. Kanneganti T, Body-Malapel M, Amer A et al.: Critical role for cryopyrin/Nalp3 in activation of caspase-1 in response to viral infection and double-stranded RNA. J. Biol. Chem. 281(48), 36560-36568 (2006).
88. Martinon F, Tschopp J: Inflammatory caspases and inflammasomes: master switches of inflammation. Cell Death Differ. 14(1), 10-22 (2007).
89. Thomas P, Dash P, Aldridge Jr et al: The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1. Immunity 30(4), 566-575 (2009).
90. Allen I, Scull M, Moore C et al.: The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity 30(4), 556-565 (2009).
91. Sadler AJ, Williams BRG: Structure and function of the protein kinase R. Curr. Top. Microbiol. Immunol. 316, 253-292 (2007).
92. Kumar A, Yang YL, Flati V et al.: Deficient cytokine signaling in mouse embryo fibroblasts with a targeted deletion in the PKR gene: role of IRF-1 and NF-kB. EMBO J. 16(2), 406-416 (1997).
93. Wong AH, Tam NW, Yang YL et al.: Physical association between STAT1 and the interferon-inducible protein kinase PKR and implications for interferon and double-stranded RNA signaling pathways. EMBO J. 16(6), 1291-1304 (1997).
94. Kumar A, Haque J, Lacoste J, Hiscott J, Williams BR: Double-stranded RNA-dependent protein kinase activates transcription factor NF-kB by phosphorylating IkB. Proc. Natl Acad. Sci. USA 91(14), 6288-6292 (1994).
95. Gil J, Esteban M: Induction of apoptosis by the dsRNA-dependent protein kinase (PKR): mechanism of action. Apoptosis 5(2), 107-114 (2000). (Pubitemid 30399384)
96. Bevilacqua PC, Cech TR: Minor-groove recognition of double-stranded RNA by the double-stranded RNA-binding domain from the RNA-activated protein kinase PKR Biochemistry 35(31), 9983-9994 (1996).
97. Cole JL: Activation of PKR: an open and shut case? Trends Biochem. Sci. 32(2), 57-62 (2007).
98. Roberts WK, Hovanessian AG, Brown RE, Clemens MJ, Kerr IM: Interferon-mediated protein kinase and low-molecular-weight inhibitor of protein synthesis Nature 264(5585), 477-480 (1976).
99. Silverman RH: Viral encounters with 2́,5́-oligoadenylate synthetase and RNase L during the interferon antiviral response. J. Virol. 81(23), 12720-12729 (2007).
100. Hartmann R, Norby PL, Martensen PM et al.: Activation of 2́-5́ oligoadenylate synthetase by single-stranded and double-stranded RNA aptamers. J. Biol. Chem. 273(6), 3236-3246 (1998).
101. Patel RC, Sen GC: Identification of the double-stranded RNA-binding domain of the human interferon-inducible protein kinase. J. Biol. Chem. 267(11), 7671-7676 (1992).
102. Ghosh SK, Kusari J, Bandyopadhyay SK, Samanta H, Kumar R, Sen GC: Cloning, sequencing, and expression of two murine 2́-5́- oligoadenylate synthetases. Structure-function relationships. J. Biol. Chem. 266(23), 15293-15299 (1991).
103. Hartmann R, Justesen J, Sarkar SN, Sen GC, Yee VC: Crystal structure of the 2́-specific and double-stranded RNA-activated interferon-induced antiviral protein 2́-5́-oligoadenylate synthetase. Mol. Cell 12(5), 1173-1185 (2003).
104. Kodym R, Kodym E, Story MD: 2́-5́-oligoadenylate synthetase is activated by a specific RNA sequence motif. Biochem. Biophys. Res. Commun. 388(2), 317-322 (2009).
105. Barber GN: The NFAR's (nuclear factors associated with dsRNA). RNA Biol. 6(1), 35-39 (2008).
106. Pfeifer I, Elsby R, Fernandez M et al.: NFAR-1 and-2 modulate translation and are required for efficient host defense. Proc. Natl Acad. Sci. USA 105(11), 4173-4178 (2008).
107. Merrill MK, Gromeier M: The double-stranded RNA binding protein 76:NF45 heterodimer inhibits translation initiation at the rhinovirus type 2 internal ribosome entry site. J. Virol. 80(14), 6936-6942 (2006).
108. Shin HJ, Kim SS, Cho YH, Lee SG, Rho HM: Host cell proteins binding to the encapsidation signal e in hepatitis B virus RNA. Arch. Virol. 147(3), 471-491 (2002).
109. Saunders LR, Perkins DJ, Balachandran S et al.: Characterization of two evolutionarily conserved, alternatively spliced nuclear phosphoproteins, NFAR-1 and-2, that function in mRNA processing and interact with the double-stranded RNA-dependent protein kinase, PKR. J. Biol. Chem. 276(34), 32300-32312 (2001).
110. Lee M, Kim Y: Signaling pathways downstream of pattern-recognition receptors and their cross talk. Ann. Rev. Biochem. 76(1), 447-480 (2007).
111. Poeck H, Bscheider M, Gross O et al.: Recognition of RNA virus by RIG-I results in activation of CARD9 and inflammasome signaling for interleukin 1b production. Nat. Immunol. 11(1), 63-69 (2009).
112. Meylan E, Tschopp J: Nlrx1: Friend or foe? EMBO Rep. 9(3), 243-245 (2008).
113. Kawai T, Akira S: Antiviral signaling through pattern recognition receptors. J. Biochem. 141(2), 137-145 (2007).
114. Zhang P, Samuel CE: Induction of protein kinase PKR-dependent activation of interferon regulatory factor 3 by vaccinia virus occurs through adapter IPS-1 signaling. J. Biol. Chem. 283(50), 34580-34587 (2008).
115. Malathi K, Dong B, Gale M, Silverman R: Small self-RNA generated by RNase L amplifies antiviral innate immunity. Nature 448(7155), 816-819 (2007).
116. Taniguchi T, Takaoka A: The interferon-a/b system in antiviral responses: a multimodal machinery of gene regulation by the IRF family of transcription factors. Curr. Opin. Immunol. 14(1), 111-116 (2002).
117. Sato M, Suemori H, Hata N et al.: Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-a/b gene induction. Immunity 13(4), 539-548 (2000).
118. Peters K, Smith H, Stark G, Sen G: IRF-3-dependent, NF-kB-and JNK-independent activation of the 561 and IFN-b genes in response to double-stranded RNA. Proc. Natl Acad. Sci. USA 99(9), 6322-6327 (2002).
119. Prescott J, Hall P, Bondu-Hawkins V, Ye C, Hjelle B: Early innate immune responses to sin nombre hantavirus occur independently of IFN regulatory factor 3, characterized pattern recognition receptors, and viral entry. J. Immunol. 179(3), 1796-1802 (2007).
120. Daffis S, Suthar M, Szretter K, Gale M, Diamond M: Induction of interferon-b and the innate antiviral response in myeloid cells through an IPS-1-dependent and IRF-3/IRF-7-independent transcriptional signal. PLoS Pathog. 5(10), e1000607 (2009).
121. Onoguchi K, Yoneyama M, Takemura A et al.: Viral infections activate types I and III interferon genes through a common mechanism. J. Biol. Chem. 282(10), 7576-7581 (2007).
122. Ank N, Iversen M, Bartholdy C et al.: An important role for type III interferon (IFN-l/IL-28) in TLR-induced antiviral activity. J. Immunol. 180(4), 2474-2485 (2008).
123. Kotenko SV, Gallagher G, Baurin VV et al.: IFN-l mediate antiviral protection through a distinct class II cytokine receptor complex. Nat. Immunol. 4(1), 69-77 (2003).
124. Levraud J-P, Boudinot P, Colin I et al.: Identification of the zebrafish IFN receptor: implications for the origin of the vertebrate IFN system. J. Immunol. 178(7), 4385-4394 (2007).
125. Perdiguero B, Esteban M: The interferon system and vaccinia virus evasion mechanisms. J. Interferon Cytokine Res. 29(9), 581-598 (2009).
126. Iqbal M, Poole E, Goodbourn S, McCauley JW: Role for bovine viral diarrhea virus Erns glycoprotein in the control of activation of b-interferon by double-stranded RNA. J. Virol. 78(1), 136-145 (2004).
127. Imani F, Jacobs BL: Inhibitory activity for the interferon-induced protein kinase is associated with the reovirus serotype 1 s3 protein. Proc. Natl Acad. Sci. USA 85(21), 7887-7891 (1988).
128. Langland JO, Pettiford S, Jiang B, Jacobs BL: Products of the porcine group C rotavirus NSP3 gene bind specifically to double-stranded RNA and inhibit activation of the interferon-induced protein kinase PKR. J. Virol. 68(6), 3821-3829 (1994).
129. Poppers J, Mulvey M, Khoo D, Mohr I: Inhibition of PKR activation by the proline-rich RNA binding domain of the herpes simplex virus type 1 US11 protein. J. Virol. 74(23), 11215-11221 (2000).
130. Poppers J, Mulvey M, Perez C, Khoo D, Mohr I: Identification of a lytic-cycle Epstein-Barr virus gene product that can regulate PKR activation. J. Virol. 77(1), 228-236 (2003).
131. Hakki M, Geballe AP: Double-stranded RNA binding by human cytomegalovirus pTRS1. J. Virol. 79(12), 7311-7318 (2005).
132. Chang HW, Watson JC, Jacobs BL: The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase. Proc. Natl Acad. Sci. USA 89(11), 4825-4829 (1992).
133. Lu Y, Wambach M, Katze MG, Krug RM: Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the eIF-2 translation initiation factor. Virology 214(1), 222-228 (1995).
134. Galabru J, Katze MG, Robert N, Hovanessian AG: The binding of double-stranded RNA and adenovirus VAI RNA to the interferon-induced protein kinase. Eur. J. Biochem. 178(3), 581-589 (1989). (Pubitemid 19026211)
135. Sharp TV, Schwemmle M, Jeffrey I et al.: Comparative analysis of the regulation of the interferon-inducible protein kinase PKR by Epstein-Barr virus RNAs EBER-1 and EBER-2 and adenovirus VAI RNA. Nucleic Acids Res. 21(19), 4483-4490 (1993).
136. Gunnery S, Rice AP, Robertson HD, Mathews MB: Tat-responsive region RNA of human immunodeficiency virus 1 can prevent activation of the double-stranded-RNA-activated protein kinase. Proc. Natl Acad. Sci. USA 87(22), 8687-8691 (1990).
137. Kumar H, Koyama S, Ishii K, Kawai T, Akira S: Cutting edge: cooperation of IPS-1-and TRIF-dependent pathways in poly IC-enhanced antibody production and cytotoxic T cell responses. J. Immunol. 180(2), 683-687 (2008).
138. Longhi M, Trumpfheller C, Idoyaga J et al.: Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant. J. Exp. Med. 206(7), 1589-1602 (2009).
139. Carter WA, Strayer DR, Hubbell HR, Brodsky I: Preclinical studies with ampligen (mismatched double-stranded RNA). J. Biol. Response Mod. 4(5), 495-502 (1985). (Pubitemid 16241548)
140. Day CW, Baric R, Cai SX et al: A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo. Virology 395(2), 210-222 (2009).
141. Ichinohe T, Ainai A, Tashiro M, Sata T, Hasegawa H: PolyI:polyc12u adjuvant-combined intranasal vaccine protects mice against highly pathogenic H5N1 influenza virus variants. Vaccine 27(45), 6276-6279 (2009).
142. Gowen BB, Wong M-H, Jung K-H et al.: TLR3 is essential for the induction of protective immunity against punta toro virus infection by the double-stranded RNA (dsRNA), poly(I:C12U), but not poly(I:C): differential recognition of synthetic dsRNA molecules. J. Immunol. 178(8), 5200-5208 (2007).
143. Jasani B, Navabi H, Adams M: Ampligen: A potential Toll-like 3 receptor adjuvant for immunotherapy of cancer. Vaccine 27(25-26), 3401-3404 (2009).
144. Behan M, Chaudhuri A, Gow J, Behan P, McKay I: Antiviral pathway activation in chronic fatigue syndrome and acute infection. Clin. Infect. Dis. 34(10), 1420-1422 (2002).
145. Suhadolnik RJ, Reichenbach NL, Hitzges P et al.: Upregulation of the 2-5A synthetase/ RNase L antiviral pathway associated with chronic fatigue syndrome. Clin. Infect. Dis. 18(Suppl. 1), S96-S104 (1994).
146. Dogusan Z, Garcia M, Flamez D et al.: Double-stranded RNA induces pancreatic B-cell apoptosis by activation of the Toll-like receptor 3 and interferon regulatory factor 3 pathways. Diabetes 57, 1236-1245 (2008).
147. Colli M, Moore F, Gurzov E, Ortis F, Eizirik D: MDA5 and PTPN2, two candidate genes for type 1 diabetes, modify pancreatic b-cell responses to the viral by-product double stranded RNA. Human Mol. Genet. 19(1), 135-146 (2010).
148. Lafyatis R, Marshak-Rothstein A: Toll-like receptors and innate immune responses in systemic lupus erythematosus. Arthritis Res. Ther. 9(6), 222 (2007).
149. Lövgren T, Eloranta M-L, Båve U, Alm GV, Rönnblom L: Induction of interferon-a production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG. Arthritis Rheum. 50(6), 1861-1872 (2004).
150. Lee JY, Marshall JA, Bowden DS: Characterization of rubella virus replication complexes using antibodies to double-stranded RNA Virology 200(1), 307-312 (1994).
151. Stollar BD, Stollar V: Immunofluorescent demonstration of double-stranded RNA in the cytoplasm of sindbis virus-infected cells. Virology 42, 276-280 (1970).
152. Westaway EG, Mackenzie JM, Kenney MT, Jones MK, Khromykh AA: Ultrastructure of kunjin virus-infected cells: colocalization of NS1 and NS3 with double-stranded RNA, and of NS2b with NS3, in virus-induced membrane structures. J. Virol. 71(9), 6650-6661 (1997).
153. Ehrenfeld E, Celma ML: Double-stranded poliovirus RNA inhibits initiation of protein synthesis by reticulocyte lysates. Proc. Natl Acad. Sci. USA 68, 1075-1078 (1971).
154. Baltimore D, Becker Y, Darnell JE: Virus-specific double-stranded RNA in poliovirus-infected cells. Science 143, 1034-1036 (1964).
155. Silverman RH, Sengupta DN: Translational regulation by HIV leader RNA, tat, and interferon-inducible enzymes. J. Exp. Pathol. 5(2), 69-77 (1990).
156. Duesberg PH, Colby C: On the biosynthesis and structure of double-stranded RNA in vaccinia virus-infected cells. Proc. Natl Acad. Sci. USA 64(1), 396-403 (1969).
157. Pettersson U, Philipson L: Synthesis of complementary RNA sequences during productive adenovirus infection. Proc. Natl Acad. Sci. USA 71(12), 4887-4891 (1974).
158. Jacquemont B, Roizman B: RNA synthesis in cells infected with herpes simplex virus. X. Properties of viral symmetric transcripts and of double-stranded RNA prepared from them. J. Virol. 15(4), 707-713 (1975).
159. Aloni Y: Extensive symmetrical transcription of simian virus 40 DNA in virus-yielding cells. Proc. Natl Acad. Sci. USA 69(9), 2404-2409 (1972).